Takeda announces positive results for mezagitamab in Phase 2 ITP study

Pallavi Madhiraju- March 14, 2024 0

Takeda Pharmaceutical Company Limited has disclosed favorable top-line outcomes from a Phase 2, randomized, double-blind, placebo-controlled trial, assessing the safety, tolerability, and efficacy of mezagitamab ... Read More

Home remedies for Arthritis: Natural ways to manage joint inflammation

Pallavi Madhiraju- May 28, 2023 0

Arthritis, characterized by joint inflammation, can cause immense pain and restrict physical movements, leading to frustration for those affected. However, there are several home remedies ... Read More

Here’s why the body may reject lung transplants

pharmanewsdaily- March 5, 2019 0

New Delhi, Mar 05 (ANI): A study led by researchers at Washington University School of Medicine in St. Louis, has identified, in mice, a process ... Read More